Rilotumumab Recruiting Phase 2 / 3 Trials for Stage IV Squamous Cell Lung Carcinoma / Recurrent Squamous Cell Lung Carcinoma / Stage IV Squamous Cell Lung Carcinoma AJCC v7 Treatment